KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Acquisitions (2016 - 2025)

Historic Acquisitions for Gsk (GSK) over the last 14 years, with Q4 2025 value amounting to -$49.2 million.

  • Gsk's Acquisitions rose 9487.41% to -$49.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.2 billion, marking a year-over-year decrease of 1579.69%. This contributed to the annual value of -$2.2 billion for FY2025, which is 11683.85% down from last year.
  • Gsk's Acquisitions amounted to -$49.2 million in Q4 2025, which was up 9487.41% from -$1.2 billion recorded in Q3 2025.
  • Gsk's Acquisitions' 5-year high stood at -$36.6 million during Q2 2024, with a 5-year trough of -$1.7 billion in Q4 2023.
  • Its 4-year average for Acquisitions is -$669.2 million, with a median of -$912.1 million in 2024.
  • In the last 5 years, Gsk's Acquisitions plummeted by 179791.43% in 2023 and then skyrocketed by 9487.41% in 2025.
  • Over the past 4 years, Gsk's Acquisitions (Quarter) stood at -$91.5 million in 2022, then tumbled by 1797.91% to -$1.7 billion in 2023, then surged by 44.71% to -$960.1 million in 2024, then skyrocketed by 94.87% to -$49.2 million in 2025.
  • Its Acquisitions stands at -$49.2 million for Q4 2025, versus -$1.2 billion for Q3 2025 and -$1.0 billion for Q1 2025.